16 Sep 2024
On Expert Voices in Dementia, Labcorp’s Joseph M. Volpe, PhD, discusses the growing role of blood-based biomarkers in improving early detection and diagnosis of Alzheimer’s disease. In conversation with Dr. Richard Isaacson, Dr. Volpe highlights how these minimally invasive tests can enhance access to care, support earlier intervention, and complement traditional diagnostic tools like PET scans and spinal taps. Listen to the full interview on The Neurology Hub to learn how Labcorp is helping to shape the next generation of Alzheimer’s diagnostics.